FIELD: biotechnology; medicine.
SUBSTANCE: present invention relates to biotechnology, specifically to production of antimicrobial peptides, and can be used in medicine for antimicrobial therapy. Polypeptide containing the sequence LKKLYKRLVKILKRWWRYLKRPVR or its modified version is highly effective against drug-resistant gram-positive and gram-negative bacteria, as well as against fungi. Besides, the polypeptide is able to prevent formation of a bacterial biofilm on plastic as well as biotic surfaces.
EFFECT: invention enables to obtain an agent with high antimicrobial activity.
13 cl, 3 dwg, 12 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIMICROBIAL PEPTIDE | 2014 |
|
RU2695455C2 |
IMMUNOGEN PEPTIDE AGAINST GROUP A STREPTOCOCCI | 2018 |
|
RU2775621C2 |
POLYPEPTIDES EXHIBITING ANTIMICROBIAL ACTIVITY AND CODING POLYNUCLEOTIDES | 2006 |
|
RU2415150C2 |
POLYPEPTIDES HAVING ANTIMICROBIAL ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | 2006 |
|
RU2512525C2 |
POLYPEPTIDES WITH ANTIMICROBIAL ACTIVITY AND POLYNUCLEOTIDES CODING THEM | 2005 |
|
RU2393224C2 |
ANTIMICROBIAL PEPTIDE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | 2011 |
|
RU2611173C2 |
COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS | 2014 |
|
RU2717306C2 |
NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-ASSOCIATED DISEASES, INCLUDING TREATMENT AND PREVENTION OF INFECTION BY MODULATING NATURAL IMMUNITY | 2006 |
|
RU2507213C2 |
MODULATION OF STRUCTURED PROTEINS SPECIFICITY | 2012 |
|
RU2631931C2 |
LYSINE POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA | 2016 |
|
RU2724545C2 |
Authors
Dates
2019-09-09—Published
2014-12-12—Filed